EEMEA Talks - Hemostasis

Bleeding disorders can affect everyone, yet many women and girls experience longer delays in receiving diagnoses. In the final episode of our podcast series on Women and Bleeding Disorders, we close our discussion with Dr. Lucia Rugeri, a specialist in clinical hemostasis, discussing the challenges of the management of bleeding disorders with special attention to challenges faced i

Bleeding disorders can affect everyone, yet many women and girls experience longer delays in receiving diagnoses. In the third episode of our podcast series on Women and Bleeding Disorders, we continue exploring with Dr. Lucia Rugeri, a specialist in clinical hemostasis, what is the situation of Patient Access to care, the state of the Education of patients and healthcare professio

Bleeding disorders can affect everyone, yet many women and girls experience longer delays in receiving diagnoses. The second episode of our podcast series on Women and Bleeding Disorders is an interview with Dr. Lucia Rugeri, a specialist in clinical hemostasis, who has dedicated her career to caring for women with bleeding and thrombotic disorders who will share with us the situat

Bleeding disorders can affect everyone, yet many women and girls experience longer delays in receiving diagnoses. We are happy to introduce you to our podcast series on Women and Bleeding Disorders. Our first episode is an interview with Naja Skow Rasmussen to share her personal story as a patient dealing with a bleeding disorder and her journey of advocacy to find effective soluti

Episode 6: In the history of Hemostasis, laboratory testing has contributed immensely to the ability of healthcare professionals to deliver the proper care. Automated instruments have revolutionized the way Labs and Lab technicians deliver results and we will be sharing the backstage of the launch of the first automated analyzer for coagulation. Join us for this series where we hos

Episode 5: In the history of Hemostasis, laboratory testing has contributed immensely to the ability of healthcare professionals to deliver the proper care. One type of assays for hemostasis is Chromogenic assays and in this episode, we will review the impact these assays have had. Join us for this series where we host Prof. Armando Tripodi who will share his wealth of experience i

Episode 4: In the history of Hemostasis, the impact of Heparin in all its formats (unfractionated or low molecular weight) has had a significant impact as an anticoagulant for the management of thrombophilic and thrombotic conditions and the history of how it started to where we are today is worth sharing. Join us for this series where we host Prof. Armando Tripodi who will share h

Episode 3: In the history of Hemostasis, the discovery of Von Willebrand Factor and its cleaving protease ADAMTS13 has expanded our understanding of primary hemostasis and the bleeding and thrombotic disorders associated with defects of either component of this axis. Join us for this series where we host Prof. Armando Tripodi who will share his wealth of experience in Hemostasis wi

Episode 2:In the history of Hemostasis, D-Dimer has evolved from a marker of fibrinolysis to several clinical use cases to help guide the diagnosis and the management of patients suspected of Venous Thromboembolism, disseminated intravascular coagulation, or guide anticoagulation therapy. Join us for this series where we host Prof. Armando Tripodi who will share his wealth of exper

Episode 1: In the history of Hemostasis, the impact of Warfarin on patient outcomes for the prevention of blood clots is immeasurable and the way this drug became a mainstay of anticoagulation therapy is quite a unique journey worth sharing. Join us for this series where we host Prof. Armando Tripodi who will share his wealth of experience in Hemostasis with all of us.